Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Ziff Capital Partners

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 9
Average round size
info
The average size of a deal this fund participated in
$87M
Portfolio companies 6
Rounds per year 1.00
Lead investments 2
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.33
Exits 1
Key employees Soon

Areas of investment

  • Biotechnology
  • Pharmaceutical
  • Health Care
  • Life Science
  • Therapeutics
Summary

In 2015 was created Ziff Capital Partners, which is appeared as VC.

Among the most popular portfolio startups of the fund, we may highlight Platelet BioGenesis. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Ediscovery, Biotechnology.

The fund is generally included in less than 2 deals every year. The high activity for fund was in 2019. The common things for fund are deals in the range of 10 - 50 millions dollars.

The usual cause for the fund is to invest in rounds with 3 partakers. Despite the Ziff Capital Partners, startups are often financed by Vivo Capital, Viventures, U.S. Department of Defense. The meaningful sponsors for the fund in investment in the same round are Qiming Venture Partners, Nest.Bio Ventures.

Read more

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Beijing Ziyi Touzi Guanli Co., Ltd Beijing, Beijing, China
Boyalife Group -
DGS -
Flexstone Partners New York, New York, United States
Fusion Fund California, Palo Alto, United States
H20 Capital Innovation Florida, Miami, United States
I-Mei -
In Good Company -
Kabu.com Securities Japan, Tokyo
Katalyst Securities -
Mandra Capital China, Hong Kong, Hong Kong Island
MAPE Advisory Group Bangalore, India, Karnataka
Musea Ventures New York, New York, United States
New York State Common Retirement Fund Albany, New York, United States
PH Capital China, Hangzhou, Zhejiang
Prana Studios California, Los Angeles, United States
RBC Dominion Securities Canada, Ontario, Toronto
Shuntai Touzi -
Toy Ventures Berkeley, California, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Corner Therapeutics

$54M18 Apr 2024 Watertown, Massachusetts, United States

Platelet BioGenesis

Biotechnology
Ediscovery
Life Science
$75M04 Nov 2021 Newton, Massachusetts, United States

Mighty Networks

Communities
Private Social Networking
Professional Networking
SaaS
Software
$50M26 Apr 2021 Palo Alto, California, United States

Affinivax

Biotechnology
Health Care
Medical
Pharmaceutical
$226M08 Jan 2021 Cambridge, Massachusetts, United States

SomaLogic

Biotechnology
Health Care
Health Diagnostics
Life Science
Medical Device
Pharmaceutical
$81M23 Dec 2020 Boulder, Colorado, United States

Imvax

Biotechnology
Pharmaceutical
Therapeutics
$112M16 Jul 2020 Philadelphia, Pennsylvania, United States

Affinivax

Biotechnology
Health Care
Medical
Pharmaceutical
$120M23 Apr 2020 Cambridge, Massachusetts, United States

Imvax

Biotechnology
Pharmaceutical
Therapeutics
$40M10 Sep 2019 Philadelphia, Pennsylvania, United States

Platelet BioGenesis

Biotechnology
Ediscovery
Life Science
$26M09 Sep 2019 Newton, Massachusetts, United States
News
Mighty Networks raises $50M to build a creator economy for the masses

– Mighty Networks, a platform designed to give creators and brands a dedicated place to start and grow communities, has closed on $50m in a Series B funding round led by Owl Ventures.
Ziff Capital Partners and LionTree Partners also participated in the financing, along with existing backers Intel Capital, Marie Forleo, Gretchen Rubin, Dan Rosensweig, Reid Hoffman, BBG Ventures and Lucas Venture Group.
– The investment brings Palo Alto-based Mighty Networks’ total raised since its 2017 inception to $67m.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Ziff Capital Partners?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 9
Average round size 87M
Rounds per year 1.00
Peak activity year 2020
Lead investments 2
Follow on index 0.33
Exits 1
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Corner Therapeutics

$54M18 Apr 2024 Watertown, Massachusetts, United States

Platelet BioGenesis

Biotechnology
Ediscovery
Life Science
$75M04 Nov 2021 Newton, Massachusetts, United States

Mighty Networks

Communities
Private Social Networking
Professional Networking
SaaS
Software
$50M26 Apr 2021 Palo Alto, California, United States

Affinivax

Biotechnology
Health Care
Medical
Pharmaceutical
$226M08 Jan 2021 Cambridge, Massachusetts, United States

SomaLogic

Biotechnology
Health Care
Health Diagnostics
Life Science
Medical Device
Pharmaceutical
$81M23 Dec 2020 Boulder, Colorado, United States

Imvax

Biotechnology
Pharmaceutical
Therapeutics
$112M16 Jul 2020 Philadelphia, Pennsylvania, United States

Affinivax

Biotechnology
Health Care
Medical
Pharmaceutical
$120M23 Apr 2020 Cambridge, Massachusetts, United States

Imvax

Biotechnology
Pharmaceutical
Therapeutics
$40M10 Sep 2019 Philadelphia, Pennsylvania, United States

Platelet BioGenesis

Biotechnology
Ediscovery
Life Science
$26M09 Sep 2019 Newton, Massachusetts, United States
Crunchbase icon

Content report

The following text will be sent to our editors: